Skip to main content

Advertisement

SpringerLink
Log in

Toward a renewable source of pancreatic β-cells

  • News & Views
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Insulin-producing cells generated from human embryonic stem cells protect mice from diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Generation of insulin-secreting cells from hES cells.

Katie Ris-Vicari

References

  1. Ricordi, C. & Strom, T. Nat. Rev. Immunol. 4, 259–268 (2004).

    Article  CAS  Google Scholar 

  2. Kroon, E. et al. Nat. Biotechnol. 26, 443–452 (2008).

    Article  CAS  Google Scholar 

  3. Kubo, A. et al. Development 131, 1651–1662 (2004).

    Article  CAS  Google Scholar 

  4. D'Amour, K.A. et al. Nat. Biotechnol. 23, 1534–1541 (2005).

    Article  CAS  Google Scholar 

  5. McLean, A.B. et al. Stem Cells 25, 29–38 (2007).

    Article  CAS  Google Scholar 

  6. D'Amour, K.A. et al. Nat. Biotechnol. 24, 1392–1401 (2006).

    Article  CAS  Google Scholar 

  7. Yang, H. & Wright, J.R. Jr. Endocrinology 143, 2491–2495 (2002).

    Article  CAS  Google Scholar 

  8. Fornoni, A. et al. Diabetologia 51, 298–308 (2008).

    Article  CAS  Google Scholar 

  9. Osafune, K. et al. Nat. Biotechnol. 26, 313–315 (2008).

    Article  CAS  Google Scholar 

  10. Yazawa, K., Fisher, W.E. & Brunicardi, F.C. World J. Surg. 26, 783–789 (2002).

    Article  Google Scholar 

  11. Schuldiner, M., Itskovitz-Eldor, J. & Benvenisty, N. Stem Cells 21, 257–265 (2003).

    Article  CAS  Google Scholar 

  12. Fareed, M.U. & Moolten, F.L. Gene Ther. 9, 955–962 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Camillo Ricordi is at the Diabetes Research Institute, University of Miami, 1450 NW 10th Avenue, Miami, Florida 33136, USA; Wake Forest Institute for Regenerative Medicine Medical Center Blvd., Winston-Salem, North Carolina 27157, USA; and the Karolinska Institutet, SE-171 77 Stockholm, Sweden. ricordi@miami.edu,

    Camillo Ricordi

  2. Wake Forest Institute for Regenerative Medicine Medical Center Blvd., Winston-Salem, North Carolina 27157, USA,

    Camillo Ricordi

  3. Helena Edlund is at the Umeå Center for Molecular Medicine, Umeå University, SE-901 87 Umeå, Sweden; and the Diabetes Research Institute, University of Miami, 1450 NW 10th Avenue, Miami, Florida 33136, USA. helena.edlund@ucmm.umu.se,

    Helena Edlund

  4. and the Diabetes Research Institute, University of Miami, 1450 NW 10th Avenue, Miami, Florida 33136, USA. helena.edlund@ucmm.umu.se,

    Helena Edlund

Authors
  1. Camillo Ricordi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helena Edlund
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

H.E. is a cofounder, shareholder and consultant of the unlisted biotech company Betagenon AB, Sweden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ricordi, C., Edlund, H. Toward a renewable source of pancreatic β-cells. Nat Biotechnol 26, 397–398 (2008). https://doi.org/10.1038/nbt0408-397

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0408-397

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation